<DOC>
	<DOCNO>NCT02932995</DOCNO>
	<brief_summary>The purpose study evaluate efficacy novel dual drug-eluting stent ( DXR stent ) , slowly release cilostazol paclitaxel , strut coverage , malapposition , thrombus formation , assess optical coherence tomography .</brief_summary>
	<brief_title>DXR Stent Vascular Healing Thrombus Formation : OCT Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Patient Age &gt; =19 year Clinically indicate invasive coronary angiography Patient capable willing give write informed consent 2 . Angiographic coronary artery disease confine native coronary artery &gt; 50 % diameter stenosis invasive coronary angiography reference diameter 2.54.0mm , lesion length â‰¤30 mm 1 . Patient Inability provide write informed consent Serious comorbidity may affect trial decision investigator Prior CABG target vessel Congestive heart failure NYHA Class III IV leave ventricular ejection fraction le 30 % Prior ST elevation myocardial infarction within 72 hour procedure Hemodynamic electrical instability include shock Serious coronary artery spasm , unrelated catheter Pregnancy possible pregnant status Allergy iodinate contrast agent Serum creatinine &gt; =1.7 mg/dL creatinine clearance &lt; = 30 ml/min ST elevation myocardial infarction 2 . Angiographic ( OCT ) Left main disease Severely calcify lesion Severely tortuous , TIMI flow grade 0 1 angiography , inappropriate OCT procedure investigator ' decision</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Optical Coherence Tomography</keyword>
	<keyword>Drug-Eluting Stent</keyword>
</DOC>